Common Contracts
26 similar Employment Agreement contracts by Seres Therapeutics, Inc., Alzheon, Inc., Homology Medicines, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • May 8th, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of February 24, 2024, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Marella Thorell (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2022 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of January 5, 2022, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Paula Cloghessy (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 20th, 2021 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of May 10, 2021, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and David Arkowitz (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2020 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of October 13, 2020, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and David S. Ege, Ph.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 28th, 2020 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 8, 2020, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Teresa Young (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 7th, 2020 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of April 2, 2020, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Lisa von Moltke, M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EX-10.6 14 d816354dex106.htm EX-10.6 EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 12, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Roger J. Pomerantz, M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 8th, 2018 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of October 5, 2018, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Kevin Horgan, M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • September 24th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 20, 2018, is made by and between Alzheon, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Martin Tolar, M.D., Ph.D. (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • September 24th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 22, 2018, is made by and between Alzheon, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Aidan Power (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • September 24th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 22, 2018, is made by and between Alzheon, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and John Hey (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • April 2nd, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 20, 2018, is made by and between Alzheon, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Martin Tolar, M.D., Ph.D. (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • April 2nd, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 22, 2018, is made by and between Alzheon, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Aidan Power (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • April 2nd, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 22, 2018, is made by and between Alzheon, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and John Hey (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • March 19th, 2018 • Homology Medicines, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 18, 2018, is made by and between Homology Medicines, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Arthur O. Tzianabos (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • March 19th, 2018 • Homology Medicines, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 18, 2018, is made by and between Homology Medicines, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Albert Seymour (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • March 19th, 2018 • Homology Medicines, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 18, 2018, is made by and between Homology Medicines, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Bradford Smith (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
Employment AgreementEmployment Agreement • March 19th, 2018 • Homology Medicines, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of March 18, 2018, is made by and between Homology Medicines, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Siyamak Rasty (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 11th, 2016 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of April 26, 2016, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Thomas J. DesRosier (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 16th, 2016 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of December 11, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Wael Hashad (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2015 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of August 10, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and John G. Aunins, Ph.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2015 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 15, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and John G. Aunins, Ph.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2015 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 13, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and David N. Cook, Ph.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2015 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 14, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Eric D. Shaff (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2015 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 12, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Roger J. Pomerantz, M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2015 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of June 13, 2015, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Michele Trucksis, Ph.D., M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
